tiprankstipranks
VistaGen Therapeutics (VTGN)
NASDAQ:VTGN
US Market

VistaGen Therapeutics (VTGN) Income Statement

Compare
817 Followers

VistaGen Therapeutics Income Statement

Last quarter (Q3 2025), VistaGen Therapeutics's total revenue was $234.00K, a decrease of -43.12% from the same quarter last year. In Q3, VistaGen Therapeutics's net income was $-14.09M. See VistaGen Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
$ 1.06M$ -227.00K$ 1.11M$ 1.09M$ 0.00
Gross Profit
$ 1.06M$ -227.00K$ 1.11M$ 1.09M$ 0.00
Operating Expenses
$ 34.09M$ 59.04M$ 48.89M$ 19.02M$ 19.97M
Depreciation and Amortization
$ 568.00K$ 532.00K$ 711.10K$ 477.60K$ 103.10K
EBITDA
$ -32.45M$ -58.74M$ -47.05M$ -17.44M$ -20.65M
Operating Income
$ -33.02M$ -59.27M$ -47.78M$ -17.93M$ -20.80M
Other Income/Expenses
$ 3.66M$ 26.00K$ 19.90K$ 2.20K$ 30.10K
Pretax Income
$ -29.36M$ -59.24M$ -47.76M$ -17.93M$ -20.77M
Net Income
$ -29.36M$ -59.25M$ -47.76M$ -17.93M$ -20.77M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.52$ -8.51$ -7.24$ -6.25$ -14.21
Diluted EPS
$ -1.52$ -8.51$ -7.24$ -6.25$ -14.21
Weighted Average Shares Outstanding
19.35M 6.96M 6.60M 2.87M 1.46M
Weighted Average Shares Outstanding (Diluted)
19.35M 6.96M 6.60M 2.87M 1.46M
Currency in USD

VistaGen Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis